Editorial: Neuroinflammation in acquired epilepsy
- PMID: 36420137
- PMCID: PMC9677101
- DOI: 10.3389/fcell.2022.1074537
Editorial: Neuroinflammation in acquired epilepsy
Keywords: BDNF; NADPH oxidase; biomarker; brain infection; epileptogenesis; oxidative stress; reactive oxygen species.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Neuroinflammation in acquired epilepsy
Similar articles
-
Crosstalk between neuroinflammation and oxidative stress in epilepsy.Front Cell Dev Biol. 2022 Aug 10;10:976953. doi: 10.3389/fcell.2022.976953. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36035987 Free PMC article. Review.
-
Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy.Redox Biol. 2019 Sep;26:101278. doi: 10.1016/j.redox.2019.101278. Epub 2019 Jul 19. Redox Biol. 2019. PMID: 31382215 Free PMC article.
-
A Brain-Heart Biomarker for Epileptogenesis.J Neurosci. 2018 Sep 26;38(39):8473-8483. doi: 10.1523/JNEUROSCI.1130-18.2018. Epub 2018 Aug 27. J Neurosci. 2018. PMID: 30150365 Free PMC article.
-
Unifying mechanism behind the onset of acquired epilepsy.Trends Pharmacol Sci. 2022 Feb;43(2):87-96. doi: 10.1016/j.tips.2021.11.009. Epub 2021 Dec 6. Trends Pharmacol Sci. 2022. PMID: 34887128 Free PMC article. Review.
-
Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase.J Cell Biol. 2002 Dec 9;159(5):821-31. doi: 10.1083/jcb.200112131. Epub 2002 Dec 2. J Cell Biol. 2002. PMID: 12460985 Free PMC article.
Cited by
-
Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: Emerging preclinical evidence of druggability.Pharmacol Ther. 2023 Apr;244:108384. doi: 10.1016/j.pharmthera.2023.108384. Epub 2023 Mar 16. Pharmacol Ther. 2023. PMID: 36933703 Free PMC article. Review.
-
Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders.Acta Pharm Sin B. 2025 May;15(5):2351-2362. doi: 10.1016/j.apsb.2025.03.024. Epub 2025 Mar 13. Acta Pharm Sin B. 2025. PMID: 40487634 Free PMC article. Review.
-
Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective.Mol Brain. 2023 Jan 25;16(1):14. doi: 10.1186/s13041-023-01008-y. Mol Brain. 2023. PMID: 36694204 Free PMC article.
-
Neuroinflammatory mediators in acquired epilepsy: an update.Inflamm Res. 2023 Apr;72(4):683-701. doi: 10.1007/s00011-023-01700-8. Epub 2023 Feb 6. Inflamm Res. 2023. PMID: 36745211 Free PMC article. Review.
-
The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders.Exp Biol Med (Maywood). 2023 May;248(9):811-819. doi: 10.1177/15353702231179926. Epub 2023 Jul 29. Exp Biol Med (Maywood). 2023. PMID: 37515545 Free PMC article. Review.
References
-
- Galanopoulou A. S., Loscher W., Lubbers L., O'Brien T. J., Staley K., Vezzani A., et al. (2021). Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open 6, 276–296. 10.1002/epi4.12490 - DOI - PMC - PubMed
-
- Korgaonkar A. A., Li Y., Sekhar D., Subramanian D., Guevarra J., Swietek B., et al. (2020). Toll-like receptor 4 signaling in neurons enhances calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and drives post-traumatic epileptogenesis. Ann. Neurol. 87, 497–515. 10.1002/ana.25698 - DOI - PMC - PubMed